ArticleNature biotechnology2013

Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity.

Ruijiang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.